Gonadal function in teens with thalassemia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how thalassemia and its treatments affect puberty and hormone function in teens aged 10 to 18. It aims to understand and possibly improve care for these young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have transfusion-dependent beta thalassemia
- You must be between 10 and 18 years old
- You cannot have any other medical condition besides thalassemia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors might affect growth in children with beta-thalassemia major who get regular blood transfusions. It aims to help understand and manage growth problems better.
This study looks at how severe thalassemia is in children and teens. If your child has thalassemia and is between 18 months and 18 years old, joining may help doctors better understand the condition.
This study looks at body composition in children with thalassemia major who receive regular blood transfusions. It aims to understand how the condition and treatment affect body fat, muscle, and overall health.
This trial tests a new gene therapy (BD211) for children and teens with severe beta-thalassemia who need regular blood transfusions. The treatment uses your own blood stem cells, modified with a working gene, to help your body make healthy red blood cells and reduce the need for transfusions.
This study looks at how children with transfusion-dependent beta-thalassemia grow and develop after gene therapy. It compares children who have had gene therapy with those who have not, and also with healthy children of the same age and gender.
This trial tests a one-time gene therapy using your own stem cells to help you produce healthy red blood cells and reduce or eliminate the need for regular blood transfusions. It is for people with transfusion-dependent beta-thalassemia who are between 3 and 35 years old.
Hear when a new Thalassemia Majors (Beta-Thalassemia Major) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.